Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

Recent application of molecular cytogenetic techniques has resulted in a new type of genetic classification of renal cell tumors. The key aspect of the novel diagnostic concept is reflected by biologically distinct entities, each characterized by a specific combination of genetic changes. To work out a diagnostic/prognostic approach, we have applied polymorphic microsatellite markers for a quick analysis, based on polymerase chain reaction, of 82 tumor specimens. We compared the results to previously evaluated cytogenetic and histological data. All nonpapillary and chromophobe renal cell carcinomas, which make up approximately 90% of all malignant renal cell tumors, and a subset of renal oncocytomas were correctly diagnosed by detection of loss of heterozygosity at chromosomal sites 1, 2, and 3p. Allelic losses at chromosomal regions 8p, 9p, and 14q are associated with an advanced pathological stage of nonpapillary renal cell carcinomas. A loss of heterozygosity at chromosomes 6, 10, 13, 17, and 21, in addition to those at chromosomes 1 and 2, confirm the diagnosis of chromophobe renal cell tumors. Using this approach, the differential diagnosis of renal cell tumors could be carried out within 1 or 2 days.

[1]  Y. Nakamura,et al.  Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. , 1992, Cancer research.

[2]  L. Jeffrey Medeiros,et al.  Adult renal epithelial neoplasms. , 1995, American journal of clinical pathology.

[3]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[4]  M H Skolnick,et al.  Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Farrow,et al.  Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. , 1995, The Journal of urology.

[6]  G. Kovacs,et al.  Cytogenetics of papillary renal cell tumors , 1991, Genes, chromosomes & cancer.

[7]  F. Marshall,et al.  Distal nephron renal tumors: microsatellite allelotype. , 1996, Cancer research.

[8]  E. Schröck,et al.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. , 1994, The American journal of pathology.

[9]  W. Thoenes,et al.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. , 1986, Pathology, research and practice.

[10]  R. Greenberg,et al.  Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Kovacs,et al.  Molecular cytogenetics of renal cell tumors. , 1993, Advances in cancer research.

[12]  G. KOVACS,et al.  Molecular differential pathology of renal cell tumours , 1993, Histopathology.

[13]  G. Kovács,et al.  Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. , 1995, Cancer research.

[14]  F. Bosman,et al.  Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. , 1994, Cancer research.

[15]  O. Olopade,et al.  Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. , 1993, Cancer research.

[16]  D. Sidransky,et al.  Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. , 1994, Cancer research.

[17]  H. Brauch,et al.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.

[18]  C. Sapienza,et al.  Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. , 1992, Cancer research.

[19]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[20]  F. Waldman,et al.  Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.

[21]  D. Sidransky,et al.  Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. , 1995, Cancer research.

[22]  G. Chenevix-Trench,et al.  Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. , 1993, Oncogene.

[23]  J. Cairns,et al.  Allelotype of human bladder cancer. , 1994, Cancer research.

[24]  J. Kirkwood,et al.  Homozygous deletions within human chromosome band 9p21 in melanoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Polascik,et al.  Novel suppressor loci on chromosome 14q in primary bladder cancer. , 1995, Cancer research.

[26]  G. Kovacs,et al.  Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. , 1989, Journal of the National Cancer Institute.